Histological Comparison of Effectiveness of Low Doses of Doxycyclineand Atorvastatin on gingival Inflammation and Alveolar Bone Loss in Experimental Model of Periodontitis in Rats
Journal of Dental School,
Vol. 35 No. 3 (2017),
27 July 2017
,
Page 84-88
https://doi.org/10.22037/jds.v35i3.24587
Abstract
Objectives: The purpose of this study was to evaluate the effect of low dose doxycycline and atorvastatin on gingival inflammation and alveolar bone loss in an experimental model of periodontitis in rats.
Methods: Forty male Sprague Dawley rats were divided into four study groups as follows: (I) experimental periodontitis control, (II) rats with periodontitis treated with low dose atorvastatin (10 mg/kg), (III) rats with periodontitis treated with low dose doxycycline (6 mg/kg) and rats with periodontitis treated with both doxycycline and atorvastatin. Periodontitis was induced by ligature placement around the upper left second molar foe seven days. The periodontitis group received saline, periodontitis/doxycycline group received doxycycline by oral gavage, periodontitis/atorvastatin group received atorvastatin by oral gavage and doxycycline/atorvastatin group received both drugs simultaneously (6 and 10 mg/kg, respectively) for 21 days after ligature placement. Then, the rats were sacrificed and their maxillae were removed, defleshed, and prepared for histopathological examination. Data were analyzed statistically by the Kruskal-Wallis test and Mann-Whitney U test at 5% level of significance and presented as frequency
Results: Using a combination of doxycycline and atorvastatin caused a significant decrease in gingival inflammation and alveolar bone loss (16.5%) and collagen degradation (13%) when compared to the control group (36.10% and 36.95%, respectively; P<0.001).
Conclusion: Low dose atorvastatin and low dose doxycycline synergically prevented alveolar bone loss and collagen degradation in ligature-induced periodontitis in rats.
- Periodontitis
- Doxycycline
- Atorvastatin Calcium
- Alveolar Bone Loss
- Collagen
How to Cite
References
Pyörälä K, Pedersen TR, Kjekshus J, Faergeman O, Olsson AG, Thorgeirsson G. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease: a subgroup analysis of the Scandinavian Simvastatin Survival Study (4S). Diabetes Care. 1997 Apr;20(4):614-20.
Armitage GC. Development of a classification system for periodontal diseases and conditions. Annals of periodontology. Ann Periodontol. 1999 Dec;4(1):1-6.
de Monès E, Schlaubitz S, Catros S, Fricain JC. Statins and alveolar bone resorption: a narrative review of preclinical and clinical studies. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015 Jan;119(1):65-73
Goes P, Lima AP, Melo IM, Rêgo RO, Lima V. Effect of Atorvastatin in radiographic density on alveolar bone loss in wistar rats. Braz Dent J. 2010;21(3):193-8.
Pantlin L. Is there a role for antibiotics in periodontal treatment? Dent update. 2008 Sep;35(7):493-6.
Vernillo A, Rifkin B. Effects of tetracyclines on bone metabolism. Adv Dent Res. 1998 Nov;12(2):56-62.
Walker C, Thomas J, Nangó S, Lennon J, Wetzel J, Powala C. Long-term treatment with subantimicrobial dose doxycycline exerts no antibacterial effect on the subgingival microflora associated with adult periodontitis. J Periodontol. 2000 Sep;71(9):1465-71.
Grevstad HJ. Doxycycline prevents root resorption and alveolar bone loss in rats after periodontal surgery. European Journal of Oral Sciences. Scand J Dent Res. 1993 Oct;101(5):287-91.
Caton JG, Ciancio SG, Blieden TM, Bradshaw M, Crout RJ, Hefti AF, et al. Treatment with subantimicrobial dose doxycycline improves the efficacy of scaling and root planing in patients with adult periodontitis. J Periodontol. 2000 Apr;71(4):521-32.
Golub LM, McNamara TF, Ryan ME, Kohut B, Blieden T, Payonk G, et al. Adjunctive treatment with subantimicrobial doses of doxycycline: effects on gingival fluid collagenase activity and attachment loss in adult periodontitis. J Clin Periodontol. 2001 Feb;28(2):146-56.
Bezerra M, Brito G, Ribeiro R, Rocha F. Low-dose doxycycline prevents inflammatory bone resorption in rats. Braz J Med Biol Res. 2002 May;35(5):613-6.
LaRosa JC, Grundy SM, Kastelein JJ, Kostis JB, Greten H. Treating to New Targets (TNT) Steering Committee and Investigators. Safety and efficacy of atorvastatin-induced very low-density lipoprotein cholesterol levels in patients with coronary heart disease (a post hoc analysis of the treating to new targets [TNT] study). Am J Cardiol. 2007 Sep;100(5):747-52.
Chandrasekar B, Mummidi S, Mahimainathan L, Patel DN, Bailey SR, Imam SZ, et al. Interleukin-18-induced human coronary artery smooth muscle cell migration is dependent on NF kappaB-and AP-1-mediated matrix metalloproteinase-9 expression and is inhibited by atorvastatin. J Biol Chem. 2006 Jun;281(22):15099-109.
Franklin RB, Costello LC. Zinc as an anti-tumor agent in prostate cancer and in other cancers. Arch Biochem Biophys. 2007 Jul;463(2):211-7.
Roux S, Amazit L, Meduri G, Guiochon-Mantel A, Milgrom E, Mariette X. RANK (receptor activator of nuclear factor kappa B) and RANK ligand are expressed in giant cell tumors of bone. Am J Clin Pathol. 2002 Feb;117(2):210-6.
Zhou Q, Liao JK. Pleiotropic effects of statins: basic research and clinical perspectives. Circ J. 2010 May;74(5):818-26.
Mundy G, Garrett R, Harris S, Chan J, Chen D, Rossini G, et al. Stimulation of bone formation in vitro and in rodents by statins. Science. 1999 Dec;286(5446):1946-9.
Ruan F, Zheng Q, Wang J. Mechanisms of bone anabolism regulated by statins. Biosci Rep. 2012 Dec;32(6):511-9.
Chen PY, Sun JS, Tsuang YH, Chen MH, Weng PW, Lin FH. Simvastatin promotes osteoblast viability and differentiation via Ras/Smad/Erk/BMP-2 signaling pathway. Nutr Res. 2010 Mar;30(3):191-9.
Moon HJ, Kim SE, Yun YP, Hwang YS, Bang JB, Park JH, et al. Simvastatin inhibits osteoclast differentiation by scavenging reactive oxygen species. Exp Mol Med. 2011 Nov;43(11):605-12.
Yamashita M, Otsuka F, Mukai T, Yamanaka R, Otani H, Matsumoto Y, et al. Simvastatin inhibits osteoclast differentiation induced by bone morphogenetic protein-2 and RANKL through regulating MAPK, AKT and Src signaling. Regul Pept. 2010 Jun;162(1-3):99-108.
Tanriverdi HA, Barut A, Sarikaya S. Statins have additive effects to vertebral bone mineral density in combination with risedronate in hypercholesterolemic postmenopausal women. Eur J Obstet Gynecol Reprod Biol. 2005 May;120(1):63-8
Ramamurthy NS, Rifkin BR, Greenwald RA, Xu J-w, Liu Y, Turner G, et al. Inhibition of matrix metalloproteinase-mediated periodontal bone loss in rats: a comparison of 6 chemically modified tetracyclines. J Periodontol. 2002 Jul;73(7):726-34.
Cho A, Suzuki S, Hatakeyama J, Haruyama N, Kulkarni AB. A method for rapid demineralization of teeth and bones. Open Dent J. 2010 Dec;4:223-9
Crossmon G. A modification of Mallory's connective tissue stain with a discussion of the principles involved. Anatom Rec. 1937 Aug;69(1):33-8.
McCulloch C, Birek P, Overall C, Aitken S, Lee W, Kulkarni G. Randomized controlled trial of doxycycline in prevention of recurrent periodontitis in high‐risk patients: antimicrobial activity and collagenase inhibition. J Clin Periodontol. 1990 Oct;17(9):616-22.
Özdemir SP, Kurtis B, Tüter G, Bozkurt S, Gültekin SE, Sengüven B, et al. Effects of low-dose doxycycline and bisphosphonate clodronate on alveolar bone loss and gingival levels of matrix metalloproteinase-9 and interleukin-1β in rats with diabetes: a histomorphometric and immunohistochemical study. J Periodontol. 2012 Sep;83(9):1172-82.
Yagan A,Kesim S, Liman N. Effect of Low-dose doxycycline on serum oxidative status, gingival antioxidant levels, and alveolar bone loss in experimental periodontitis in rats. Journal of periodontology .2014;85(3):478-89.
Lindy O, Suomalainen K, Mäkelä M, Lindy S. Statin use is associated with fewer periodontal lesions: A retrospective study. BMC oral health. 2008 May;8:16
Cunha-Cruz J, Saver B, Maupome G, Hujoel PP. Statin use and tooth loss in chronic periodontitis patients. J Periodontol. 2006 Jun;77(6):1061-6.
Saxlin T, Suominen‐Taipale L, Knuuttila M, Alha P, Ylöstalo P. Dual effect of statin medication on the periodontium. J Clin Periodontol. 2009 Dec;36(12):997-1003.
Fentoglu O,Kirzioglu F,Ozdem M,Kocak H, Sutcu R, Sert T. Pro inflammatory cytokine levels in hyper lipidemic patients with periodontitis after periodontal treatment. Oral diseases. 2012;18(3):299-306
De Araújo Júnior , Souza TO, de Moura LM, Torres KP, de Souza LlB, Alves Mdo S. Atorvastatin decreases bone loss, inflammation and oxidative stress in experimental periodontitis. PloS one. 2013;10:e75322.
- Abstract Viewed: 238 times
- PDF Downloaded: 234 times